Sidley Austin advised IO Biotech, and Latham & Watkins advised the placement agents.IO Biotech, Inc. (Nasdaq: IOBT) announced that it has entered into a definitive securities…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
